Common chemicals acting together may be carcinogenic to humans
the ONA take:
Common chemicals not considered to be carcinogenic to humans at low doses may act together to increase cancer risk, according a 3-year investigation conducted by a task force comprised of nearly 200 researchers from 28 countries.
Of the 85 chemicals studied, 50 were found to disrupt normal cell function in ways that are known to be associated with early signs of cancer.
Chemicals studied included bisphenol A (BPA), a chemical used in plastics, rotenone, an insecticide, paraquat, a herbicide, triclosan, an antibacterial agent, and EDTA, a metal-ion-binding compound used in manufacturing and medicine.
"Our findings also suggest these molecules may be acting in synergy to increase cancer activity," said William Bisson, an assistant professor and cancer researcher at OSU and a team leader on the study.
EDTA alone does not cause gene mutations, but when exposed to that and something else that is mutagenic, the effect of DNA repair disruption is enhanced.
The findings suggest that more research is warranted to evaluate early exposure to these common chemicals and how those chemicals affect the early stages of cancer development.
Common chemicals not considered to be carcinogenic to humans at low doses may act together to increase cancer risk.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Eischens Yoga May Benefit Men Undergoing Radiation Therapy for Prostate Cancer
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|